Inhibition of RAAS—When is it too much?

Keywords

Division (mathematics), Computer science, Algebraic operation, Algorithm, Arithmetic

References

• Effects of the addition of a low dose of spironolactone on brain natriuretic peptide plasma level and cardiopulmonary function in patients with moderate congestive heart failure.Mauro Feola, Endrj Menardi, Flavio Ribichini — 2003
• Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials.Paul G Shekelle, Michael W. Rich, Sally C. Morton — 2003
• Delayed effects of one-year treatment with low-dose as compared with high-dose enalapril on morbidity and mortality of patients with severe heart failureRudolf Berger, B Frey, Martin Hülsmann — 1998
• Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators.Robert S. McKelvie, Salim Yusuf, Dan Pericak — 1999
• Angiotensin-independent mechanism for aldosterone synthesis during chronic extracellular fluid volume depletion.Soichiro Okubo, Fumio Niimura, Hideki Nishimura — 1997
• Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).Karl Swedberg, John Kjekshus — 1988
• Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. Vasodilator-Heart Failure Trial Study Group.Peter E. Carson, Susan Ziesche, Gary R. Johnson — 1999
• Angiotensin-Converting Enzyme Inhibition Increases Human Vascular Tissue-Type Plasminogen Activator Release Through Endogenous BradykininMias Pretorius, David A. Rosenbaum, Douglas E. Vaughan — 2003
• Aldosterone blockade and heart failure.Mariell Jessup — 2003
• Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease.Craig Barr, Chim C. Lang, Jacqueline Hanson — 1995
• Efficacy of angiotensin-converting enzyme inhibition in reducing progression from asymptomatic left ventricular dysfunction to symptomatic heart failure in black and white patients.Daniel L. Dries, Mark Strong, Richard Cooper — 2002
• Development of circulatory-renal limitations to angiotensin-converting enzyme inhibitors identifies patients with severe heart failure and early mortality.M. Kittleson, Shelley Hurwitz, Monica Shah — 2003
• Addition of angiotensin II receptor blockade to maximal angiotensin-converting enzyme inhibition improves exercise capacity in patients with severe congestive heart failure.Glenn S. Hamroff, Stuart D. Katz, Donna Mancini — 1999
• Angiotensin and its AT2 receptor: new insights into an old system.Monika Stoll, Thomas A. Unger — 2001
• A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.Jay N. Cohn, Gianni Tognoni — 2001
• Angiotensin receptor blockers in heart failure: meta-analysis of randomized controlled trials.Philip Jong, Catherine Demers, Robert S. McKelvie — 2002
• Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up study.Philip Jong, Salim Yusuf, Michel F. Rousseau — 2003
• Long-term, dose-dependent effects of spironolactone on left ventricular function and exercise tolerance in patients with chronic heart failure.Mariantonietta Cicoira, Luisa Zanolla, Andrea Rossi — 2002
• Long-term effects of clinical outcome with low and high dose in the Captopril in Heart Insufficient Patients Study (CHIPS)Denis Clément, Marc De Buyzere, Marc TOMAS — 2000
• Outcome of patients with congestive heart failure treated with standard versus high doses of enalapril: a multicenter study. High Enalapril Dose Study Group.John N. Nanas, George P. Alexopoulos, Maria Anastasiou‐Nana — 2000

Cited by

• Exercise Training after Myocardial Infarction Attenuates Dysfunctional Ventricular Remodeling and Promotes Cardiac RecoveryShuqing Liu, Xinxiu Meng, Guoping Li — 2022
• The impact of Sacubitril/Valsartan on cardiac fibrosis early after myocardial infarction in hypertensive ratsYihai Liu, Chongxia Zhong, Jiayi Si — 2022
• Acceleration of Iterative Refinement for Singular Value DecompositionYuki Uchino, Takeshi Terao, Katsuhisa Ozaki — 2022
• Operator Dependant Compensated AlgorithmsPhilippe Langlois, Nicolas Louvet — 2006
• Performance Evaluation of an Efficient Double-Double BLAS1 Function With Error-Free Transformation and its Application to Explicit Extrapolation MethodsTomonori Kouya — 2019
• Pentagon Functions for Scattering of Five Massless ParticlesChicherin, D., Sotnikov, V. — 2020
• Colour and logarithmic accuracy in final-state parton showersHamilton, K, Medves, R, Salam, GP — 2021

Related papers

• A floating-point technique for extending the available precisionT.J. Dekker — 1971
• MPFR: A multiple-precision binary floating-point library with correct roundingLaurent Fousse, Guillaume Hanrot, Vincent Lefèvre — 2007
• Accurate Sum and Dot ProductTakeshi Ogita, Siegfried M. Rump, Shin’ichi Oishi — 2005
• The Art of Computer Programming. Volume 2: Seminumerical Algorithms.Olga Taussky, Donald E. Knuth — 1970